Molly Henderson

2023 - Phathom Pharmaceuticals

In 2023, Molly Henderson earned a total compensation of $1.9M as Chief Financial and Business Officer at Phathom Pharmaceuticals, a 29% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$260,888
Option Awards$281,105
Salary$500,000
Stock Awards$814,925
Other$16,875
Total$1,873,793

Henderson received $814.9K in stock awards, accounting for 43% of the total pay in 2023.

Henderson also received $260.9K in non-equity incentive plan, $281.1K in option awards, $500K in salary and $16.9K in other compensation.

Rankings

In 2023, Molly Henderson's compensation ranked 572nd out of 2,918 executives tracked by ExecPay. In other words, Henderson earned more than 80.4% of executives.

ClassificationRankingPercentile
All
572
out of 2,918
80th
Division
Manufacturing
327
out of 1,608
80th
Major group
Chemicals And Allied Products
228
out of 901
75th
Industry group
Drugs
225
out of 864
74th
Industry
Pharmaceutical Preparations
141
out of 622
77th
Source: SEC filing on April 12, 2024.

Henderson's colleagues

We found two more compensation records of executives who worked with Molly Henderson at Phathom Pharmaceuticals in 2023.

2023

Terrie Curran

Phathom Pharmaceuticals

Chief Executive Officer

2023

Azmi Nabulsi

Phathom Pharmaceuticals

Chief Operating Officer

News

You may also like